Spectral Medical Inc.
EDTXF
$0.5796
-$0.0005-0.09%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 40.94% | 11.57% | 7.63% | -0.41% | -7.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.94% | 11.57% | 7.63% | -0.41% | -7.75% |
| Cost of Revenue | 33.20% | 34.30% | 50.71% | 54.59% | 30.87% |
| Gross Profit | 51.90% | -11.13% | -26.95% | -37.20% | -35.01% |
| SG&A Expenses | 5.47% | 15.76% | 19.06% | 40.22% | 25.55% |
| Depreciation & Amortization | 206.04% | 180.84% | 179.10% | 42.87% | 11.42% |
| Other Operating Expenses | -30.05% | -33.11% | 582.17% | 1,203.66% | 6,519.35% |
| Total Operating Expenses | 10.84% | 19.87% | 28.99% | 44.77% | 28.36% |
| Operating Income | -6.53% | -21.32% | -33.00% | -55.09% | -35.97% |
| Income Before Tax | 0.95% | -141.11% | -106.47% | -170.12% | -94.92% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.95% | -141.11% | -106.47% | -170.12% | -94.92% |
| Earnings from Discontinued Operations | 95.54% | 97.71% | 92.28% | 96.33% | 95.90% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.88% | -111.95% | -68.62% | -86.96% | -33.57% |
| EBIT | -6.53% | -21.32% | -33.00% | -55.09% | -35.97% |
| EBITDA | -6.49% | -22.06% | -33.96% | -57.09% | -37.68% |
| EPS Basic | 2.40% | -110.26% | -66.00% | -81.68% | -29.19% |
| Normalized Basic EPS | -2.83% | -138.10% | -100.00% | -159.13% | -82.96% |
| EPS Diluted | 2.40% | -110.26% | -66.00% | -81.68% | -29.19% |
| Normalized Diluted EPS | -2.83% | -138.10% | -100.00% | -159.13% | -82.96% |
| Average Basic Shares Outstanding | 0.94% | 0.82% | 1.48% | 2.32% | 3.23% |
| Average Diluted Shares Outstanding | 0.94% | 0.82% | 1.48% | 2.32% | 3.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |